Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 877 across all filing types
Latest filing 2016-03-31 Share Issue/Capital Cha…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Förändring av aktier och antal röster i Episurf Medical AB
Share Issue/Capital Change Classification · 98% confidence The document is a press release dated March 31, 2016, announcing a change in the number of shares and votes in Episurf Medical AB due to the conversion of A-shares to B-shares. This directly relates to a change in the company's capital structure (share classes and total count). This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes to the capital structure, including share class adjustments. It is not an Earnings Release (ER), Interim Report (IR), or a general Regulatory Filing (RNS), as it concerns a specific structural change.
2016-03-31 Swedish
Change in shares and number of votes in Episurf Medical AB
Share Issue/Capital Change Classification · 98% confidence The document is a short company announcement dated March 31, 2016, detailing a change in the number of shares (conversions of class A to class B shares) and the resulting total number of shares and votes. This directly relates to changes in the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes in share count, rather than a general regulatory filing (RNS) or a dividend announcement (DIV). The length is short, but the content is a direct notification of a capital structure event, making SHA more specific than RPA or RNS.
2016-03-31 English
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding ('Reason for major shareholding notification Sell') by Avanza Bank Holding AB for a specific number of shares (795,714) resulting in a new percentage (4.98% directly held shares, 3.48% indirectly held voting rights). This structure, focusing on changes in significant ownership thresholds, directly corresponds to the definition of a Major Shareholding Notification. The code for this is MRQ.
2016-03-08 English
Vetenskaplig artikel (peer reviewed) avseende Episurf Medicals implantatteknologi har publicerats
Legal Proceedings Report Classification · 99% confidence The document is a press release dated March 4, 2016, announcing that a peer-reviewed scientific article regarding the company's implant technology has been published in the journal 'Osteoarthritis and Cartilage'. The text focuses on the publication of scientific validation data, not the release of periodic financial results (ER/IR), a formal annual report (10-K), or a general regulatory filing (RNS). Since the core purpose is to announce the publication of external scientific/medical validation, and there is no specific category for 'Scientific Publication Announcement', the most appropriate classification is the general 'Regulatory Filings' (RNS) as a formal announcement of material information, or potentially 'LTR' if the scientific validation is considered a key legal/regulatory event, but RNS is the standard fallback for non-standard announcements. Given the context of a press release announcing a publication, RNS is the best fit among the provided options, as it is an official announcement of material information not covered by other specific codes.
2016-03-04 Swedish
Scientific peer reviewed article regarding Episurf Medical´s implant technology has been published
Environmental & Social Information Classification · 99% confidence The document is titled "Company Announcement" dated March 4, 2016, and its primary content is announcing that a scientific peer-reviewed article regarding the company's implant technology has been published in the journal 'Osteoarthritis and Cartilage'. It includes quotes from the CEO and Medical Advisor about the significance of this publication. This is not a formal regulatory filing like a 10-K, an earnings release (ER), or a comprehensive interim report (IR). It is an announcement about external validation/research, which does not fit neatly into the primary financial reporting categories. Given the options, it is a general announcement that doesn't fit the specific categories like DIRS, DIV, or CAP. Therefore, it falls best under the general regulatory/company announcement category, which is 'Regulatory Filings' (RNS), as it is a general disclosure required by securities acts mentioned at the end, but lacks a more specific classification.
2016-03-04 English
Episurf Medical has been granted additional US patent
Regulatory Filings Classification · 95% confidence The document is a short 'Company Announcement' dated February 25, 2016, titled 'Episurf Medical has been granted additional US patent.' The content focuses entirely on the granting of a new patent covering manufacturing methods for patient-specific implants and surgical tools. This relates to intellectual property protection and innovation, which is a core aspect of corporate activity but does not fit neatly into the primary financial reporting categories (10-K, IR, ER, etc.). Since it is a specific announcement about intellectual property (IP) protection, it is best classified under 'Intellectual Property' or, if that is not available, as a general regulatory filing. Reviewing the provided codes, 'IP' stands for Investor Presentation, which is incorrect. 'LTR' is for Legal Proceedings Report, which is also incorrect. Given the focus on patents and IP, and lacking a specific 'IP Filing' code, this announcement is a specific corporate update that is not a financial report, management change, or dividend notice. It is most appropriately categorized as a general Regulatory Filing (RNS) as it is a press release disclosing material information, or potentially related to the company's core assets/innovation strategy. Since it is a specific announcement about a patent grant, and 'RNS' is the general regulatory fallback, I will use RNS. However, if we interpret 'IP' as Intellectual Property Filing (even though the definition says Investor Presentation), that would be a better fit. Given the strict definitions, and that this is a press release disclosing material information not covered by other specific codes, RNS is the safest fallback. Let's re-examine the definitions. None explicitly cover patent grants. RNS (Regulatory Filings) is the catch-all for miscellaneous regulatory announcements. Confidence is high that it is not a financial report or management change.
2016-02-25 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.